Aids risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders

Journal of Addictive Diseases

Volumn 17, Issue 4, 1998, Pages 33-48

  Abbott, Patrick J ^a   Moore, Brent A ^b   Weller, Susan B ^b   Delaney, Harold D ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; COMMUNITY; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHADONE TREATMENT; MULTIVARIATE ANALYSIS; RISK; SOCIAL ADAPTATION; SYMPTOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RISK-TAKING; SOCIAL BEHAVIOR;

EID: 0031765440     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v17n04_04     Document Type: Article

References (34)

1. Des Jaríais DC. Cross-national studies of AIDS among injecting drug users. Addiction. 1994; 89:383-392.
2. Centers for Disease Control: HIV/AIDS Surveillance Report, Vol.6, 2. Washington, DC, Department of Health and Human Services: Fall 1995.
3. Wodak AD, Crofts N, Fisher R. HIV infection among injecting dmg users in Asia: An evolving public health crisis. AIDS Care. 1993; 22:549-562.
4. McLellan AT, Luborsky L, Woody GE, et al. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983; 40:620-625.
5. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy for opiate addicts: Does it help? Arch Gen Psychiatry. 1983; 40:639-645.
6. Abbot PA, Weller SB, Delaney HD, Moore BA. Community Reinforcement Approach in the treatment of opiate addiction. Am J Dmg Alcohol Abuse. (In Press)
7. Reiger D, Farmer M, Rae D. Comorbidity of mental disorders with alcohol and other dmg abuse: Results from the Epidemiologic Catchment Area study. JAMA. 1990; 264:2511-2518.
8. Abbott PA, Weller SB, Walker SR. Psychiatric disorders of opioid addicts entering treatment: Preliminary data J Addict. 1994; 13:1-11.
9. Khantzian EJ, Treece C. DSM-IH psychiatric diagnosis of narcotic addicts: Recent findings. Arch Gen Psychiatry. 1985; 42:1067-1071.
10. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry. 1982; 39:161-166.
11. Silberstein C, Galanter M, Marmor M, et al. HIV-1 among inner city dually diagnosed inpatients. Am JDmg Alcohol Abuse. 1994; 20:101-113.
12. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous dmg abusers. Am J Psychiatry. 1993; 150:53-58.
13. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Arch Gen Psychiatry. 1986; 43:739-745.
14. Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous dmg abusers with antisocial personality disorder: Increased HIV risk behavior. Dmg Alcohol Depend. 1990; 26:39-44.
15. Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug Alcohol Depend. 1992; 30:247-252.
16. Metzger DS, Woody GE, De Philippis D, et al. Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry. 1991; 148:636-640.
17. Federal Register, Part IE, 54, (40), 21 CER Part 291, Rockville, MD: US Department of Health and Human Services, Food and Dmg Administration: 1989.
18. McLellan AT, Luborsky L, Cacciola J, et al. New data from the Addiction Severity Index: Reliability and validity in three centers. J Nerv Ment Dis. 1985; 173:412-423.
19. Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the Addition Severity Index. JNerv MentDis. 1983; 171:606-610.
20. Derogatis LR. SCL-90-R: Administration, scoring and procedures manual II. Rockville, MD: Clinical Psychometric Research, 1983.
21. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90. A study in construct validation. J Clin Psychol. 1977; 33:981-989.
22. Derogatis LR, Cleary PA. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Brit J Soc Clin Psychol. 1977; 16:347-356.
23. Beck AT, Ward CH, MendeIson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:53-63.
24. Beck AT. Depression inventory. Philadelphia, PA: Center for Cognitive Therapy. 1978.
25. Metzger DS, De Phillips D, Druley P, et al. The impact of HIV testing on risk of AIDS behaviors. Problems of drug dependence 1991: Proceeding of the 53rd Annual Scientific Meeting. NIDA Res Monogr, 119. 1992; 297-298.
26. Weissman MM, Both well S. Assessment of social adjustment by patient selfreport. Arch Gen Psychiatry. 1976; 33:1111-1115.
27. Weissman MM, Paykel ES, Prusoff BA. Social adjustment scale handbook: Rationale, reliability, and validity. 1990.
28. Spitzer RL, Williams JBW, Gibbon M, First B. Structured clinical interview for DSM-M-R patient version (SCID-P, 6/1/88). New York: Biometrics Research Department, State Psychiatric Institute, 1988.
29. Williams JBW, Gibbon M, First B, Spitzer RL. The Structured Clinical Interview for DSM-III-R (SCID): n. Miiltisite test-retest reliability. Arch Gen Psychiatry. 1992; 49:630-636.
30. Spitzer RL, Williams JBW, Gibbon M, First B. User’s guide for the structured clinical interview for DSM-III-R (SCID). Washington, DC: American Psychiatric Press, 1990.
31. Cohen J. A coefficient of agreement of nominal scales. Educ Psychol Meas. 1960; 20:37-46.
32. Mosier Cl. Problems and designs of cross-validation. Educ Psychol Meas. 1960; 11:5-11.
33. McCusker J, Golstein R, Bigelow C, Zom M. Psychiatric status and HIV risk reduction among residential drug abuse treatment clients. Addiction. 1995; 90:1377-1387.
34. New Mexico Department of Health, Division of Epidemiology, Evaluation and Planning. Epidemiology report, High prevalence of hepatitis and low prevalence of HTV among injection drug users in Bernalillo and Dona Ana counties. July 1995.